Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Respiratory Drugs Companies

Numerous pharmaceutical companies worldwide are involved in the research, development, and production of respiratory drugs to address conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders.

Latest Respiratory Drugs Companies Update

AstraZeneca (UK) Launched the first triple-fixed combination therapy for COPD in Europe, Breztri Aerosolizer®, offering improved symptom control and reduced exacerbations. Received FDA approval for Fasenra® (benralizumab) for severe eosinophilic asthma, expanding their portfolio of biologics for difficult-to-treat respiratory diseases.

GlaxoSmithKline (GSK) (UK) Partnered with Verve Therapeutics to develop new gene therapy candidates for severe asthma and other respiratory diseases. Announced positive Phase 3 results for Nucala® (mepolizumab) in chronic rhinosinusitis with nasal polyps, potentially opening up new market opportunities.

Novartis (Switzerland) Received European Commission approval for Xolair® (omalizumab) for the treatment of chronic severe asthma in children aged 6 to 11 years, broadening their pediatric reach. Focused on developing inhaled therapies for lung cancer, partnering with companies like BeiGene to bring targeted treatments to patients

Teva Pharmaceutical Industries Ltd. (Israel) Introduced a generic version of Advair®, a popular inhaled therapy for COPD and asthma, offering cost-effective options for patients and impacting market dynamics. Invested in digital health solutions like connected inhalers and mobile apps to improve medication adherence and disease management for respiratory patients.

List of Respiratory Drugs Key companies in the market

VAPOTHERM

AptarGroup, Inc.

Drägerwerk AG & CO.

Allied Healthcare

Cardinal Health

NSPIRE HEALTH INC.

Koninklijke Philips N.V.

Respiratory Drugs Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.